Bioxytran (BIXT) Price to Sales (2011 - 2018)
Bioxytran's Price to Sales was 521.76 in Q2 2018, up 422.4% from 99.88 a year earlier but down 18.8% from the prior quarter.
Powered by 
Analysis
Bioxytran (BIXT) Price to Sales (2011 - 2018) Analysis & Trends
For FY2017, Price to Sales at Bioxytran came in at 434.04, up 630.5% from FY2016.
- In earlier years, Price to Sales was 59.42 in FY2016 (+8.5%), 54.78 in FY2015 (-71.7%), 193.87 in FY2014 (-99.5%) and 41109.01 in FY2013 (+44.5%).
- Quarterly Price to Sales has moved between 51.47 (Q3 2017) and 115117.17 (Q3 2013) over five years.
- Compared with a year earlier, Price to Sales has increased for three straight quarters.
- The best year-over-year quarter for Price to Sales over five years was Q1 2018 (growth of 852.0%); the worst was Q4 2014 (a decline of 99.5%).
- Per Business Quant data, BIXT's Price to Sales in the three quarters before Q2 2018 was 642.27 (Q1 2018), 434.04 (Q4 2017) and 51.47 (Q3 2017).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Bioxytran | 2.29 Mn | 1.13 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2018 | 521.76 |
| Mar 31, 2018 | 642.27 |
| Dec 31, 2017 | 434.04 |
| Sep 30, 2017 | 51.47 |
| Jun 30, 2017 | 99.88 |
| Mar 31, 2017 | 67.46 |
| Dec 31, 2016 | 59.42 |
| Sep 30, 2015 | 141.82 |
| Jun 30, 2015 | 193.98 |
| Mar 31, 2015 | 134.48 |
| Dec 31, 2014 | 193.87 |
| Sep 30, 2014 | 7,959.94 |
| Jun 30, 2014 | 12,378.72 |
| Mar 31, 2014 | 23,729.61 |
| Dec 31, 2013 | 41,108.91 |
| Sep 30, 2013 | 115,117.17 |
| Jun 30, 2013 | 30,867.61 |
| Mar 31, 2013 | 37,280.76 |
| Dec 31, 2012 | 27,685.47 |
| Sep 30, 2012 | 33,394.62 |
API Access
Bioxytran Price to Sales API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=price-to-sales&ticker=BIXT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "price-to-sales", "ticker": "BIXT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=price-to-sales&ticker=BIXT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();